NHS Stock Recent News

NHS's 2023 rights offering results are in. The offering was oversubscribed, despite the slim discount to the market price. The "sell and rebuy" strategy worked once again.

Quick notes on Neuberger Berman High Yield Strategies' rights offering this year. Our suggestion is to sell before the ex-rights date and rebuy after the offering.

NHS is a fixed income closed end fund. The fund focuses on U.S. high yield bonds, which represent 88% of the portfolio.

NHS is a fixed income closed end fund. Over 88% of the fund holdings are fixed rate high yield bonds.